Comparison of Free Radicals and Antioxidant Enzymes in Chronic Otitis Media with and without Tympanosclerosis

Laryngoscope

Volumn 114, Issue 1, 2004, Pages 85-89

  Karlidaǧ, Turgut ^a   Ilhan, Nevin ^a   Kaygusuz, Irfan ^a   Keleş, Erol ^a   Yalçin, Şinasi ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Free oxygen radicals; Nitric oxide; Tympanosclerosis

Indexed keywords

ALKALINE PHOSPHATASE; ANTIOXIDANT; CALCITONIN; CATALASE; FREE RADICAL; MALONALDEHYDE; NITRIC OXIDE; OXYGEN RADICAL; PARATHYROID HORMONE; PHOSPHATE; POTASSIUM; SODIUM; SUPEROXIDE DISMUTASE;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; AUDITORY OSSICLE; BLOOD SAMPLING; CALCITONIN BLOOD LEVEL; CHRONIC OTITIS MEDIA; CONTROLLED STUDY; DEMOGRAPHY; EAR DISEASE; EARDRUM; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MASTOID; MASTOIDECTOMY; MIDDLE EAR MUCOSA; NOSE POLYP; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SODIUM BLOOD LEVEL; TYMPANOPLASTY; TYMPANOSCLEROSIS; VENOUS BLOOD;

ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; CATALASE; CHRONIC DISEASE; FEMALE; FREE RADICALS; HUMANS; MALE; MALONDIALDEHYDE; MASTOID; MIDDLE AGED; NITRIC OXIDE; NITRITES; OTITIS MEDIA; PROSPECTIVE STUDIES; SCLEROSIS; SUPEROXIDE DISMUTASE; TYMPANIC MEMBRANE; TYMPANOPLASTY;

EID: 0942276154     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200401000-00014     Document Type: Article

References (28)

1. Forseni M, Bagger-Sjoback D, Hultcrantz M. A study of inflammatory mediators in the human tympanosclerotic middle ear. Arch Otolaryngol Head Neck Surg 2001;127:559-564.
2. Flodin MF, Hultcrantz. Possible inflammatory mediators in tympanosclerosis development. Int J Pediatr Otorhinolaryngol 2002;63:149-154.
3. da Costa SS, Paparella MM, Schachern PA, Yoon TH, Kimberley BP. Temporal bone histopathology in chronically infected ears with intact and perforated tympanic membranes. Laryngoscope 1992;102:1229-1236.
4. Tos M, Stangerup SE. Hearing loss in tympanosclerosis caused by grommets. Arch Otolaryngol Head Neck Surg 1989;115:931-935.
5. Wielinga EWJ, Kerr AG. Tympanosclerosis. Clin Otolaryngol 1993;18:341-349.
6. Ryan AF, Bennett T. Nitric oxide contributes to control of effusion in experimental otitis media. Laryngoscope 2001;111:301-305.
7. Bhaya MH, Schachern PA, Morizono T, Paparella MM. Pathogenesis of tympanosclerosis. Otolaryngol Head Neck Surg 1993;109:413-420.
8. John EO, Russell PT, Nam B, Jinn TH, Jung TT. Concentration of nitric oxide metabolites in middle ear effusion. Int J Pediatr Otorhinolaryngol 2001;60:55-58.
9. Koutnouyan HA, Baird A, Ryan AF. Acidic and basic FGF mRNA expression in the middle ear mucosa during experimental acute and chronic otitis media. Laryngoscope 1994;104:350-358.
10. Parks RR, Huang CC, Haddad J Jr. Evidence of oxygen radical injury in experimental otitis media. Laryngoscope 1994;104:1389-1392.
11. Friedman AD, Shah JB, Takoudes TG, Haddad J Jr. The role of free radicals in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2002;128:1055-1057.
12. Mattsson C, Magnuson K, Hellstrom S. Myringosclerosis caused by increased oxygen concentration in traumatized tympanic membranes: experimental study. Ann Otol Rhinol Laryngol 1995;104:625-632.
13. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990;36:1440-1443.
14. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
15. Satoh K. Serum Lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978;90:37-43.
16. Yagi K. Assay of blood plasma or serum. Methods Enzymol 1984;105:328-331.
17. Podczasy JJ, Wei R. Reduction of iodonitrotetrazolium violet by superoxide radicals. Biochem Biophys Res Com 1988;150:1294-1301.
18. Van Kampen EJ, Zijlstra WG. Determination of hemoglobin and its derivatives. Adv Clin Chem 1965;8:141-187.
19. Aebi H. Catalase in vitro assay methods. Methods Enzimol 1984;105:121-126.
20. Goth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 1991;196:143-152.
21. Ozcan C, Gorur K, Cinel L, Talas DU, Unal M, Cinel I. The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane. Int J Pediatr Otorhinolaryngol 2002;63:179-184.
22. Tos M, Bonding P, Poulsen G. Tympanosclerosis of the ear drum in secretory otitis media after insertion of grommets: a prospective, comparative study. J Laryngol Otol 1983;97:489-496.
23. Rae D, Gatland DJ, Youngs R, Cook J. Aspiration of middle ear effusions prior to grommet insertion an etiological factor in tympanosclerosis. J Otolaryngol 1989;18:229-231.
24. Mattsson C, Carlsson L, Marklund SL, Hellstrom S. Myringotomized mice develop myringosclerosis in the pars flaccida and not in the pars tensa. Laryngoscope 1997;107:200-205.
25. Jackson TS, Xu A, Vita JA, Keaney JF Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 1998;83:916-922.
26. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med 1994;120:227-237.
27. Hukkanen M, Hughes FJ, Buttery LD, et al. Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 1995;136:5445-5453.
28. Spratley JE, Hellstrom SO, Mattsson CK, Pais-Clemente M. Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes: a study in the rat. Ann Otol Rhinol Laryngol 2001;110:585-591.